OtherClinical Investigations (Human)
18F-FDG PET derived tumor blood flow changes after one cycle of neoadjuvant chemotherapy predicts outcome in triple-negative breast cancer
Olivier HUMBERT, Jean-Marc Riedinger, Jean-Marc Vrigneaud, Salim Kanoun, Inna Digay-Cochet, alina Berriolo-Riedinger, Michel Toubeau, Edouard Depardon, maud Lasserre, simon Tisserand, Pierre Fumoleau, François Brunotte and Alexandre Cochet
Journal of Nuclear Medicine April 2016, jnumed.116.172759; DOI: https://doi.org/10.2967/jnumed.116.172759
Olivier HUMBERT
1 CENTRE GEORGES-FRANCOIS LECLERC, France;
Jean-Marc Riedinger
1 CENTRE GEORGES-FRANCOIS LECLERC, France;
Jean-Marc Vrigneaud
1 CENTRE GEORGES-FRANCOIS LECLERC, France;
Salim Kanoun
1 CENTRE GEORGES-FRANCOIS LECLERC, France;
Inna Digay-Cochet
1 CENTRE GEORGES-FRANCOIS LECLERC, France;
alina Berriolo-Riedinger
1 CENTRE GEORGES-FRANCOIS LECLERC, France;
Michel Toubeau
1 CENTRE GEORGES-FRANCOIS LECLERC, France;
Edouard Depardon
1 CENTRE GEORGES-FRANCOIS LECLERC, France;
maud Lasserre
1 CENTRE GEORGES-FRANCOIS LECLERC, France;
simon Tisserand
1 CENTRE GEORGES-FRANCOIS LECLERC, France;
Pierre Fumoleau
1 CENTRE GEORGES-FRANCOIS LECLERC, France;
François Brunotte
2 LE2I UMR 6306, CNRS, Arts et Métiers, Univ. Bourgogne Franche-Comté, France;
Alexandre Cochet
3 Centre Georges-Francois Leclerc, France

Article Figures & Data
Additional Files
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
18F-FDG PET derived tumor blood flow changes after one cycle of neoadjuvant chemotherapy predicts outcome in triple-negative breast cancer
Olivier HUMBERT, Jean-Marc Riedinger, Jean-Marc Vrigneaud, Salim Kanoun, Inna Digay-Cochet, alina Berriolo-Riedinger, Michel Toubeau, Edouard Depardon, maud Lasserre, simon Tisserand, Pierre Fumoleau, François Brunotte, Alexandre Cochet
Journal of Nuclear Medicine Apr 2016, jnumed.116.172759; DOI: 10.2967/jnumed.116.172759
18F-FDG PET derived tumor blood flow changes after one cycle of neoadjuvant chemotherapy predicts outcome in triple-negative breast cancer
Olivier HUMBERT, Jean-Marc Riedinger, Jean-Marc Vrigneaud, Salim Kanoun, Inna Digay-Cochet, alina Berriolo-Riedinger, Michel Toubeau, Edouard Depardon, maud Lasserre, simon Tisserand, Pierre Fumoleau, François Brunotte, Alexandre Cochet
Journal of Nuclear Medicine Apr 2016, jnumed.116.172759; DOI: 10.2967/jnumed.116.172759
Jump to section
Related Articles
Cited By...
- Principles of Tracer Kinetic Analysis in Oncology, Part II: Examples and Future Directions
- Breast Cancer Blood Flow and Metabolism on Dual-Acquisition 18F-FDG PET: Correlation with Tumor Phenotype and Neoadjuvant Chemotherapy Response
- 2-18F-Fluoroethanol Is a PET Reporter of Solid Tumor Perfusion
- Getting the Most out of 18F-FDG PET Scans: The Predictive Value of 18F-FDG PET-Derived Blood Flow Estimates for Breast Cancer